Vasculogenesis in infantile hemangioma

被引:202
作者
Boscolo, Elisa [1 ]
Bischoff, Joyce [1 ]
机构
[1] Harvard Univ, Childrens Hosp, Sch Med, Dept Surg,Vasc Biol Program, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
Angiogenesis; Endothelial cells; Endothelial progenitor cells; Hemangioma; Vasculogenesis; VEGF-receptors; ENDOTHELIAL PROGENITOR CELLS; MESENCHYMAL STEM-CELLS; GROWTH-FACTOR; IN-VIVO; DIFFERENTIAL EXPRESSION; MICROARRAY ANALYSIS; TIE2; RECEPTOR; MAST-CELLS; E-SELECTIN; TUMOR;
D O I
10.1007/s10456-009-9148-2
中图分类号
R6 [外科学];
学科分类号
100210 [外科学];
摘要
Infantile hemangioma is a vascular tumor that occurs in 5-10% of infants of European descent. A defining feature of infantile hemangioma is the dramatic growth and development into a disorganized mass of blood vessels. Subsequently, a slow spontaneous involution begins around 1 year of age and continues for 4-6 years. The growth and involution of infantile hemangioma is very different from other vascular tumors and vascular malformations, which do not regress and can occur at any time during childhood or adult life. Much has been learned from careful study of the tissue morphology and gene expression patterns during the life-cycle of hemangioma. Tissue explants and tumor-derived cell populations have provided further insight to unravel the cellular and molecular basis of infantile hemangioma. A multipotent progenitor cell capable of de novo blood vessel formation has been isolated from infantile hemangioma, which suggests that this common tumor of infancy, long considered to be a model for pathologic angiogenesis, may also represent pathologic vasculogenesis. Whether viewed as angiogenesis or vasculogenesis, infantile hemangioma represents a vascular perturbation during a critical period of post-natal growth, and as such provides a unique opportunity to decipher mechanisms of human vascular development.
引用
收藏
页码:197 / 207
页数:11
相关论文
共 83 条
[1]
Differential expression of active mitogen-activated protein kinase in cutaneous endothelial neoplasms: Implications for biologic behavior and response to therapy [J].
Arbiser, JL ;
Weiss, SW ;
Arbiser, ZK ;
Bravo, F ;
Govindajaran, B ;
Caceres-Rios, H ;
Cotsonis, G ;
Recavarren, S ;
Swerlick, RA ;
Cohen, C .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 44 (02) :193-197
[2]
Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature [J].
Au, Patrick ;
Tam, Joshua ;
Fukumura, Dai ;
Jain, Rakesh K. .
BLOOD, 2008, 111 (09) :4551-4558
[3]
Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy [J].
Barlow, CF ;
Priebe, CJ ;
Mulliken, JB ;
Barnes, PD ;
Mac Donald, D ;
Folkman, J ;
Ezekowitz, RAB .
JOURNAL OF PEDIATRICS, 1998, 132 (03) :527-530
[4]
Barnes Carmen M., 2007, Lymphatic Research and Biology, V5, P245, DOI 10.1089/lrb.2007.1018
[5]
Evidence by molecular profiling for a placental origin of infantile hemangioma [J].
Barnés, CM ;
Huang, S ;
Kaipainen, A ;
Sanoudou, D ;
Chen, EJ ;
Eichler, GS ;
Guo, YC ;
Yu, Y ;
Ingber, DE ;
Mulliken, JB ;
Beggs, AH ;
Folkman, J ;
Fishman, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (52) :19097-19102
[6]
The Pathogenesis of Hemangiomas: A Review [J].
Bauland, Constantijn G. ;
van Steensel, Maurice A. M. ;
Steijlen, Peter M. ;
Rieu, Paul N. M. A. ;
Spauwen, Paul H. M. .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2006, 117 (02) :29E-35E
[7]
Berard M, 1997, AM J PATHOL, V150, P1315
[8]
Familial segregation of hemangiomas and vascular malformations as an autosomal dominant trait [J].
Blei, F ;
Walter, J ;
Orlow, SJ ;
Marchuk, DA .
ARCHIVES OF DERMATOLOGY, 1998, 134 (06) :718-722
[9]
Complications of systemic corticosteroid therapy for problematic hemangioma [J].
Boon, LM ;
MacDonald, DM ;
Mulliken, JB .
PLASTIC AND RECONSTRUCTIVE SURGERY, 1999, 104 (06) :1616-1623
[10]
Clonality and altered behavior of endothelial cells from hemangiomas [J].
Boye, E ;
Yu, Y ;
Paranya, G ;
Mulliken, JB ;
Olsen, BR ;
Bischoff, J .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (06) :745-752